When will Labcorp announce Q2 results?

The date has not been set yet, but it is expected within the coming weeks.

What are the revenue expectations for Q2?

Expectations have not been announced, but analysts anticipate revenue growth compared to $3.2 billion in Q2 2024.

What is driving Labcorp's growth currently?

Labcorp is growing due to diagnostics, specialty testing, and new strategic collaborations.

Labcorp Prepares for Q2 Earnings: Revenue and EPS Expected to Rise

Q: Is the company expected to provide future guidance?

Yes, management is expected to provide guidance for Q3 and full-year 2025 during the earnings call.

Labcorp (LH) is preparing to report its Q2 2025 earnings, with analysts expecting higher revenues and EPS. The optimism is fueled by growth in diagnostics, specialty testing, and new strategic collaborations.

Labcorp (NYSE: LH) is gearing up to report its second-quarter fiscal 2025 earnings, with expectations of higher revenue and earnings per share compared to the same period last year. The momentum is driven by growth in diagnostics, specialty testing, and new strategic collaborations.

Key Financial Metrics

The company has not yet released Q2 results, but expectations include:

Metric	Q2 2025 (Expected)	Q2 2024 (Actual)
Revenue	Not yet announced	$3.2 billion
EPS	Not yet announced	$2.45

Highlights from the Report

No official statement has been released yet, but analysts are focusing on:

Growth in core diagnostics.
Expansion of specialty testing.
Impact of new collaborations with strategic partners.

Future Guidance

Management is expected to provide guidance for Q3 and full-year 2025 during the earnings call.

Impact on the Stock

Labcorp's stock is currently trading near its 52-week high, and beating expectations could lead to further upside.

What This Means for Investors

Investors should closely monitor diagnostics and specialty testing results, as they are key growth drivers. Strong guidance could support the stock in the near term.